Kyverna Therapeutics (KYTX) Stock Chart & Stock Price History $2.12 -0.01 (-0.47%) As of 12:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kyverna Therapeutics Stock Price Performance 5 Day Performance+13.98%1 Month Performance-9.79%3 Month Performance-41.11%6 Month Performance-57.34%Year-To-Date Performance-43.32%1 Year Performance-88.03% Receive KYTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kyverna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address KYTX Stock Chart for Thursday, April, 24, 2025 KYTX Chart by TradingView Kyverna Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2025$2.10$2.13+1.43%$2.23$2.09227,532 shs$92.06 million04/22/2025$1.99$2.10+5.53%$2.12$1.92292,973 shs$90.76 million04/21/2025$1.86$1.99+6.99%$2.05$1.82263,617 shs$86.01 million04/18/2025$1.86$1.86$1.95$1.78286,269 shs$80.38 million04/17/2025$1.83$1.86+1.64%$1.95$1.78286,269 shs$80.38 million04/16/2025$1.99$1.83-8.04%$2.02$1.82221,989 shs$79.08 million04/15/2025$2.23$1.99-10.76%$2.26$1.97190,626 shs$86.00 million04/14/2025$2.06$2.23+8.25%$2.27$2.00284,194 shs$96.37 million04/11/2025$1.87$2.06+10.16%$2.06$1.84167,487 shs$89.02 million04/10/2025$1.94$1.87-3.61%$1.94$1.81173,064 shs$80.81 million Get the Latest News and Ratings for KYTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kyverna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/09/2025$1.87$1.94+3.74%$2.07$1.81254,157 shs$83.84 million04/09/2025$1.87$1.94+3.74%$2.07$1.81254,157 shs$83.84 million04/08/2025$1.91$1.87-2.09%$2.02$1.83254,648 shs$80.81 million04/08/2025$1.91$1.87-2.09%$2.02$1.83254,648 shs$80.81 million04/07/2025$1.98$1.91-3.54%$2.08$1.79348,992 shs$82.54 million04/04/2025$1.97$1.98+0.51%$2.00$1.86334,476 shs$85.57 million04/03/2025$2.15$1.97-8.37%$2.10$1.94243,276 shs$85.05 million04/02/2025$1.98$2.15+8.59%$2.16$1.92277,915 shs$92.82 million04/01/2025$1.93$1.98+2.59%$2.08$1.88310,407 shs$85.48 million03/31/2025$2.00$1.93-3.50%$2.03$1.90408,909 shs$83.32 million03/28/2025$2.36$2.00-15.25%$2.43$1.99820,978 shs$86.34 million03/27/2025$2.50$2.36-5.60%$2.57$2.34186,477 shs$101.89 million03/26/2025$2.30$2.50+8.70%$2.52$2.29280,688 shs$107.93 million03/25/2025$2.35$2.30-2.13%$2.39$2.29208,195 shs$99.30 million03/24/2025$2.38$2.35-1.26%$2.43$2.27236,145 shs$101.45 million Related Companies CKPT Stock Price Chart TECX Stock Price Chart RGNX Stock Price Chart OLMA Stock Price Chart BNTC Stock Price Chart CMPS Stock Price Chart TKNO Stock Price Chart ALLO Stock Price Chart TRDA Stock Price Chart ARCT Stock Price Chart Receive KYTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kyverna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KYTX) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Intuitive Surgical at $1.99. Nvidia at $11. Shorting Fannie Mae months before collapse. That’s this analyst’s ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kyverna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kyverna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.